Artificial Intelligence in Remote Patient Monitoring Market is Expected to Grow with a CAGR of More Than 27%: Know Key Drivers and Market Opportunities | DelveInsight

Groundbreaking Market Analysis Reveals 27.13% CAGR Growth as Healthcare Industry Embraces Artificial Intelligence-Powered Remote Monitoring Solutions to Address Global Chronic Disease Burden

DelveInsight Business Research, a leading pharmaceutical market research and business consulting firm, today released its comprehensive market analysis report on Artificial Intelligence in Remote Patient Monitoring, projecting exponential growth from ~USD 2 billion in 2024 to USD 13 billion by 2032. This represents a substantial compound annual growth rate of more than 27% during the forecast period from 2025 to 2032, driven by an increasing prevalence of chronic diseases, technological advancements, and global digital health infrastructure investments.

The AI-powered remote patient monitoring market encompasses advanced medical devices, software platforms, and services that integrate artificial intelligence technology to enable continuous, real-time health monitoring outside traditional clinical settings. This market transformation addresses critical healthcare challenges, including rising hospital costs, chronic disease management inefficiencies, and the growing need for proactive, data-driven patient care solutions.

Recent Developments Accelerate Market Momentum

According to DelveInsight's comprehensive Artificial Intelligence (AI) in Remote Patient Monitoring Market Insights, Competitive Landscape, and Market Forecast report, the artificial intelligence in remote patient monitoring landscape has witnessed significant innovations in 2025. In September 2025, Apple introduced the Apple Watch Series 11 featuring groundbreaking hypertension notifications that alert users to signs of chronic high blood pressure, a feature developed using advanced machine learning with training data from over 100,000 participants and validated in clinical studies of more than 2,000 participants. With FDA clearance expected imminently, this feature is anticipated to notify over 1 million people with undiagnosed hypertension within its first year across more than 150 countries.

Additionally, Medtronic has enhanced its IoT-enabled remote patient monitoring ecosystem by integrating AI-powered analytics engines with connected medical devices including pacemakers, glucose monitors, and insulin pumps, enabling real-time physiological data transmission through secure telemetry networks. Philips partnership with Western Australia Health demonstrated remarkable clinical and economic outcomes through the Health in a Virtual Environment (HIVE) service, which reduced intensive care unit hours by 69% and saved AU$2,682 per patient while maintaining patient safety standards.

In May 2025, iRhythm Technologies launched its Zio ECG Recording and Analysis System in Japan, featuring a PMDA-approved deep-learned AI algorithm that detects 13 arrhythmia types and performs at cardiologist-level accuracy, demonstrating 99% patient compliance and 99% analyzable data quality. Meanwhile, GE HealthCare partnered with Biofourmis in February 2024 to integrate AI-powered monitoring into its FlexAcuity platform, further expanding the competitive landscape.

More Recent developments @ https://www.delveinsight.com/sample-request/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

AI in Remote Patient Monitoring Market Drivers and Epidemiological Imperatives

According to the DelveInsight report, the rising global cancer burden significantly drives demand for AI-powered remote patient monitoring solutions. The Global Cancer Observatory reported 20 million new cancer cases globally in 2022, with projections estimating this figure will reach ~25 million by 2030.

The International Diabetes Federation reports that ~540 million adults aged 20-79 live with diabetes globally, a number expected to increase to ~650 million by 2030 and reach 780 million by 2045. Over 75% of adults with diabetes reside in low- and middle-income countries, with an additional 540 million adults experiencing impaired glucose tolerance, placing them at elevated risk for developing type 2 diabetes. These epidemiological trends underscore the critical need for continuous monitoring and early intervention capabilities that AI-enabled RPM devices provide through real-time glucose level tracking, complication detection, and personalized treatment plan optimization.

AI in Remote Patient Monitoring Market Segmentation and Product Innovation

The artificial intelligence in the remote patient monitoring market is segmented by product type (devices, software, and services), application (cancer, cardiovascular disorders, lifestyle disorders, and others), end-user (hospitals and clinics, diagnostic centers, and homecare settings), and geography (North America, Europe, Asia-Pacific, and Rest of World) in DelveInsight's report.

AI-enabled remote monitoring devices represent a major market segment, featuring continuous vital signs tracking including heart rate, blood pressure, blood oxygen saturation, and electrocardiograms. Advanced functionalities include wireless data transmission to cloud platforms, personalized health feedback, medication reminders, and seamless integration with electronic health record systems and telehealth platforms. Notable product innovations include Apple Watch Series 9 with ECG and SpO2 monitoring, iRhythm's Zio Patch for long-term ECG monitoring powered by AI algorithms, and Medtronic's LINQ II insertable cardiac monitor for long-term abnormal heart rhythm detection.

Which segment is expected to dominate the market? Know @ https://www.delveinsight.com/sample-request/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

North America Dominates Market Share

North America is anticipated to dominate the artificial intelligence in remote patient monitoring market throughout the forecast period from 2025 to 2032, attributed to rising chronic disease burden, robust healthcare infrastructure, high digital health technology adoption rates, and supportive government policies. The Centers for Disease Control and Prevention reports that 800K Americans experience myocardial infarction annually, while approximately 6.2 million adults suffer from heart failure in the United States alone in 2022.

The Canadian Cardiovascular Society reported that 2.5% of Canada's population had heart disease in 2022, increasing significantly after age 65 to reach 13% after age 75, with projections estimating 1.5 million Canadians over 65 will have heart disease by 2040. This increasing cardiovascular disease burden drives demand for continuous monitoring solutions that enable early detection, real-time management, and personalized care to reduce complications and improve outcomes in aging populations.

Delve deeper into the regional segmentation of the evolving landscape @ https://www.delveinsight.com/sample-request/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Key AI Companies in Patient Monitoring Devices Market and Competitive Landscape

Leading companies operating in the artificial intelligence in remote patient monitoring market include Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., AliveCor Inc., Biofourmis, Optum Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, and Biobeat. Recent company evaluations highlight Medtronic, Philips, and GE Healthcare as market leaders with AI-integrated solutions and strategic expansions.

Industry analyses demonstrate that these key players actively invest in research and development, form strategic partnerships, and engage in collaborative initiatives to drive innovation, expand global footprint, and maintain competitive advantages in this rapidly evolving market. Medtronic's consistent revenue growth from 2019 to 2023 underscores its stable market presence and industry leadership, while its collaborations with Cardiac Design Labs and Abbott enhance offerings aimed at improving patient outcomes through integrated AI solutions.

Which company is expected to dominate the AI in Remote Patient Monitoring landscape? For a complete analysis of the competitive landscape, visit https://www.delveinsight.com/sample-request/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Market Challenges and Future Outlook

Despite robust growth potential, the artificial intelligence in the remote patient monitoring market faces challenges, including data privacy and security concerns, stringent regulatory compliance requirements, and complexities in AI integration that could impact growth trajectories. Healthcare organizations must navigate diverse regulatory frameworks including HIPAA in the United States and GDPR in Europ,e while implementing robust encryption techniques, access control mechanisms, and cybersecurity measures to protect sensitive patient information.

The shift from reactive to proactive healthcare represents one of the most significant transformations in medical practice, with predictive analytics increasingly developing customized treatment plans based on patients' genetic profiles, lifestyle factors, and environmental backgrounds. As multimodal AI systems combining voice, visual, and biometric data mature, healthcare providers gain comprehensive diagnostic capabilities and can create truly personalized treatment plans while enhancing security through multiple biometric verification layers.

Request DelveInsight's comprehensive Artificial Intelligence in Remote Patient Monitoring Market Report @ https://www.delveinsight.com/sample-request/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: info@delveinsight.com
Phone: +14699457679
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.

This release was published on openPR.